학술논문

Catalase and PPARγ2 genotype and risk of systemic lupus erythematosus in Koreans.
Document Type
Article
Source
Lupus. 2005, Vol. 14 Issue 5, p351-355. 5p.
Subject
*SYSTEMIC lupus erythematosus
*GENETIC polymorphisms
*AUTOIMMUNE diseases
*GENETIC research
*HEALTH facilities
*INTERNAL medicine
Language
ISSN
0961-2033
Abstract
Catalase (CAT) and peroxisome proliferator activated receptor-γ2 (PPARγ2) are important regulators of oxidative stress and inflammation, which may contribute to the development of systemic lupus erythematosus (SLE). The objective of this study was to investigate the effects of genetic polymorphisms of CAT and PPARγ2 on risk and severity of SLE in a Korean population. DNA was isolated from blood samples collected from 345 patients with SLE and 400 controls. Genotyping for the -262C→T polymorphism of CAT and the Pro12Ala polymorphism of PPARγ2 were performed by PCR-RFLP analysis. The severity of SLE was assessed using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index (SDI). No association was observed between genotypes for any of the clinical manifestations of SLE. CAT and PPARγ2 genotypes were not associated with either risk or severity of SLE. For subjects who were carriers of the high activity T allele for CAT and have the Pro/Pro genotype for PPARγ2, the odds ratio (95% confidence interval) for risk of SLE was 0.45 (0.23–1.08). Our results suggest that genetic polymorphisms of CAT and PPARγ2 do not play a significant role in the development of SLE in a Korean population. A possible protective effect of a combined genotype warrants further investigation. [ABSTRACT FROM AUTHOR]